Información de la revista
Vol. 108. Núm. 3.
Páginas 268-271 (abril 2017)
Visitas
6765
Vol. 108. Núm. 3.
Páginas 268-271 (abril 2017)
Case and Research Letter
Acceso a texto completo
Lymphangioma-like Kaposi sarcoma
Sarcoma de Kaposi de tipo linfangiomatoso
Visitas
6765
F. Martínez-Ortiza,
Autor para correspondencia
Juliusmr2013@gmail.com

Corresponding author.
, M.P. Gómez Avivarb
a Servicio de Anatomía Patológica, UGC Biotecnología, Hospital Torrecárdenas, Almería, Spain
b Servicio de Dermatología, Hospital Torrecárdenas, Almería, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (2)
Tablas (1)
Table 1. Lymphangioma-like Kaposi Sarcoma Affecting the Skin: Cases Published to Date.
Texto completo
To the Editor:

Lymphangioma-like Kaposi sarcoma (LLKS) is a rare histologic variant of Kaposi sarcoma that can present as any of the 4known clinical variants. LLKS is a vascular neoplasm that develops secondary to infection by human herpesvirus type 8 (HHV-8), which is also known as the Kaposi sarcoma virus. Clinically, it can present with the usual manifestations, namely, patches, plaques, or nodules. However, in some cases, it presents as blisters that may be confused with bullous skin disease.

Case Description

The patient was an 80-year-old man whose history was unremarkable. He presented with raised erythematous, oval plaques measuring 1-3cm in diameter that had first appeared 5 years previously. The plaques occasionally coalesced and were found on the upper and lower limbs and lower back. The lesions had gradually increased in number and size, although they were neither painful nor pruriginous. The physical examination revealed flaccid blisters (1cm) containing serum (Fig. 1). Treatment with various topical options had been unsuccessful.

Figure 1.

Coalescent erythematous-squamous plaques and blisters measuring 1 to 3cm on the lower limbs.

(0.28MB).

A complete laboratory workup including complete blood count and biochemistry revealed iron-deficiency anemia. Serology testing for HIV was negative.

Histopathology revealed that the epidermis was conserved and highlighted a proliferation of anastomosed vascular spaces that occupied the complete thickness of the dermis, dissected the collagen bundles, and surrounded cutaneous muscles and adnexa. No blood was identified in these structures. Clusters of lymphocytes and plasma cells were common in the stroma. Closer examination revealed that the vascular channels were lined with a layer of flattened endothelial cells and that there was no atypia or mitosis. Immunohistochemistry showed that tumor proliferation was positive for the endothelial markers CD31 and CD34 and for the lymphatic marker D2-40. It also showed clear nuclear staining for latent nuclear antigen 1 of HHV-8 (Fig. 2).

Figure 2.

A, Anastomosed, small-caliber vascular channels with no content dissecting collagen bundles (hematoxylin-eosin, original magnification, ×10). B, Expression of CD34 (×10). C, Expression of D2-40 (×10). D, Expression of HHV-8 (×10).

(0.67MB).

The patient was diagnosed with LLKS and referred to the medical oncology department. Given the poorly aggressive clinical course and the patient's age, it was decided—after evaluation and with the patient's agreement—to adopt a wait-and-see approach.

Discussion

LLKS is a malignant vascular neoplasm with evidence of lymph and blood vessel differentiation. It is a rare histologic variant of Kaposi sarcoma (5% of cases)1 and can present in any of the 4existing epidemiologic variants. Etiology and pathogenesis are controversial, as is the question of whether the disease should be classified as reactive or neoplastic.2 The discovery of HHV-8, which is present in 100% of cases of Kaposi sarcoma, irrespective of the subtype in question, is a major finding in our knowledge of the etiology and pathogenesis of the condition.3 Similarly, the question of cell differentiation is controversial, since cells express both specific blood and lymph markers.4,5

Clinical Manifestations

The most common presentation of LLKS is blisters,6 although it can also appear in the more classic form of plaques or nodules. LLKS can also present as a mucocutaneous lesion, affecting mainly the legs and arms. The condition is more common in males, with a mean age at onset of 45.1 years (Table 1). Despite the low number of cases reported in the literature, data seem to indicate that LLKS is more indolent than the classic variety, although cases with an aggressive course have been reported.7,8

Table 1.

Lymphangioma-like Kaposi Sarcoma Affecting the Skin: Cases Published to Date.

Study, y  Clinical Type  Age  Sex  Clinical Lesions  Onset of Kaposi Sarcoma  Distribution of Lesions  Behavior 
Gange and Jones, 1979  Classic KS  82  Blisters  2 y  Generalized  Slow progression 
  Classic KS  55  Papules  3 y  Generalized  Slow progression 
  Classic KS  72  Papules  10 y  Generalized  Slow progression 
Leibowitz, 1980  Endemic KS  34  Blisters  Unknown  Generalized  Aggressive 
Davis and Scott, 2000  KS-AIDS  35  Macules  5 y  Generalized  Slow progression 
Noel et al., 1997  Endemic KS  42  Plaques  Unknown  Localized  Slow progression 
Cossu et al., 1997  Classic KS  77  Blisters  8 y  Localized  Slow progression 
  Classic KS  71  Blisters  2 mo  Generalized  Aggressive 
  Classic KS  66  Blisters  3 y  Generalized  Slow progression 
  Classic KS  80  Macules  2 mo  Localized  Slow progression 
  Classic KS  75  Papules  5 y  Localized  Slow progression 
  Classic KS  71  Papules  3 y  Generalized  Slow progression 
  Classic KS  59  Macules  1 mo  Generalized  Slow progression 
Roncheses and Kern, 1957)  Classic KS  68  Blisters  4 y  Generalized  Slow progression 
  Classic KS  65  Blisters  Unknown  Generalized  Slow progression 
Bossuyt et al., 1995)  KS-AIDS  57  Nodules  1 y  Generalized  Slow progression 
De la Torre et al., 1998)  KS-AIDS  25  Nodule  Unknown  Generalized  Died 4 mo later 
Ramírez et al., 2005)  Classic KS  83  Blisters  3 y  Legs  Slow progression 
  KS-AIDS  38  Plaques and nodules  2 mo  Neck, chest, right arm  Slow progression 
  Classic KS  75  Papules  1 y  Legs  Unknown 
  KS-AIDS  40  Papules and plaques  3 y  Legs  Slow progression 
Mohanna et al., 2006)  Classic KS  65  Blisters  8 y  Legs and arms  Slow progression 
  Classic KS  89  Blisters and nodules  1 mo  Legs  Slow progression 
  Classic KS  61  Plaques and nodules  1 y  Legs  Slow progression 
  KS-AIDS  36  Plaques and nodules  7mo  Legs  Died 2 mo later 
Friedman et al., 2013)  Classic KS  85  Gangrene  2 wk  Right foot  Slow progression 
Agustí-Mejías et al., 2011)  Classic KS  75  Plaque  8 y  Right leg and arm  Slow progression 
Present case  Classic KS  80  Plaques and nodules  5 y  Legs and back  Slow progression 

Abbreviation: KS; Kaposi sarcoma.

Histologically, the disease is characterized by ectatic vascular spaces with a labyrinthine architecture that dissect collagen bundles and dermal adnexa and are accompanied by a nodular lymphoplasmacytic infiltrate. The vascular structures are lined with flattened endothelial cells with no mitosis and no—or very scant—atypia. The cells of Kaposi sarcoma express endothelial cell markers (CD31 and CD34) and lymphatic markers (D2-40), as well as HHV-8.9 The differential histologic diagnosis should be with other vascular tumors that show an infiltrative growth pattern between the collagen bundles or that comprises spindle cells, as is the case with low-grade angiosarcoma, kaposiform hemangioendothelioma, spindle cell hemangioma, hobnail angioma (targetoid hemosiderotic hemangioma), and benign lymphangioendothelioma.10 The condition can also present as lymphangiectasia, although it is easy to detect this form with histopathology, which reveals dilation of pre-existing lymph vessels and absence of new formations, as occurs in the lymphangiomatous type.

Treatment

LLKS can be systemic or local, depending on the epidemiologic type, the patient's immune status, and the number of lesions. Local treatment can be carried out with liquid nitrogen–based cryotherapy, radiotherapy, laser, or intralesional injections with chemotherapy agents or interferon. Systemic treatment can be administered with interferon or chemotherapy agents.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References
[1]
C. Posada García, A. García-Cruz, I. García-Doval, C. de la Torre, M.J. Cruces.
Lymphangioma-like Kaposi sarcoma: Case report.
Dermatol Online J., 15 (2009), pp. 13
[2]
L. Requena, O.P. Sangueza.
Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms.
J Am Acad Dermatol., 38 (1998), pp. 143-175
[3]
Y. Chang, E. Cesarman, M.S. Pessin, F. Lee, J. Culpepper, D.M. Knowles, et al.
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
Science., 266 (1994), pp. 1865-1869
[4]
J.L. Rutgers, R. Wieczorek, F. Bonetti, K.L. Kaplan, D.N. Posnett, A.E. Friedman-Kien, et al.
The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin.
Am J Pathol., 122 (1986), pp. 493-499
[5]
S. Breiteneder-Geleff, A. Soleiman, H. Kowalski, R. Horvat, G. Amann, E. Kriehuber, et al.
Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium.
Am J Pathol., 154 (1999), pp. 385-394
[6]
S. Mohanna, J. Sanchez, J.C. Ferrufino, F. Bravo, E. Gotuzzo.
Lymphangioma-like Kaposi's sarcoma: Report of four cases and review.
J Eur Acad Dermatol Venereol JEADV., 20 (2006), pp. 1010-1011
[7]
S. Cossu, R. Satta, F. Cottoni, G. Massarelli.
Lymphangioma-like variant of Kaposi's sarcoma: Clinicopathologic study of seven cases with review of the literature.
Am J Dermatopathol., 19 (1997), pp. 16-22
[8]
M.R. Leibowitz, M. Dagliotti, E. Smith, J.F. Murray.
Rapidly fatal lymphangioma-like Kaposi's sarcoma.
Histopathology., 4 (1980), pp. 559-566
[9]
H. Schmid, C. Zietz.
Human herpesvirus 8 and angiosarcoma: Analysis of 40 cases and review of the literature.
Pathology (Phila)., 37 (2005), pp. 284-287
[10]
J.A. Ramirez, W.B. Laskin, J. Guitart.
Lymphangioma-like Kaposi sarcoma.
J Cutan Pathol., 32 (2005), pp. 286-292

Please cite this article as: Martínez-Ortiz F, Avivar MG. Sarcoma de Kaposi de tipo linfangiomatoso. Actas Dermosifiliogr. 2017;108:268–271.

Copyright © 2016. Elsevier España, S.L.U. and AEDV
Descargar PDF
Idiomas
Actas Dermo-Sifiliográficas
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?